174 related articles for article (PubMed ID: 34856110)
1. Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Lambert N; Dauby S; Dive D; Sadzot B; Maquet P
Emerg Infect Dis; 2022 Jan; 28(1):253-6. PubMed ID: 34856110
[TBL] [Abstract][Full Text] [Related]
2. Update on progressive multifocal leukoencephalopathy.
Steiner I; Berger JR
Curr Neurol Neurosci Rep; 2012 Dec; 12(6):680-6. PubMed ID: 22991070
[TBL] [Abstract][Full Text] [Related]
3. Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome.
Giacomini PS; Rozenberg A; Metz I; Araujo D; Arbour N; Bar-Or A;
N Engl J Med; 2014 Jan; 370(5):486-8. PubMed ID: 24476450
[No Abstract] [Full Text] [Related]
4. Gone over to the dark side: Natalizumab-associated JC virus infection of neurons in cerebellar gray matter.
Dang X; Koralnik IJ
Ann Neurol; 2013 Oct; 74(4):503-5. PubMed ID: 23913509
[No Abstract] [Full Text] [Related]
5. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
[TBL] [Abstract][Full Text] [Related]
6. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R
Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874
[TBL] [Abstract][Full Text] [Related]
7. JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
Schippling S; Kempf C; Büchele F; Jelcic I; Bozinov O; Bont A; Linnebank M; Sospedra M; Weller M; Budka H; Martin R
Ann Neurol; 2013 Oct; 74(4):622-6. PubMed ID: 23868420
[TBL] [Abstract][Full Text] [Related]
8. Progressive multifocal leukoencephalopathy treated with nivolumab.
Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
[TBL] [Abstract][Full Text] [Related]
9. [Progressive multifocal leukoencephalopathy and natalizumab-related immune reconstitution inflammatory syndrome: the advantage of MRI].
Gibelin N; Daelman L; Goulipian S; Wynckel A; Chaunu MP; Tourbah A
Rev Neurol (Paris); 2014 Jan; 170(1):48-50. PubMed ID: 24139244
[No Abstract] [Full Text] [Related]
10. Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
N'gbo N'gbo Ikazabo R; Mostosi C; Quivron B; Delberghe X; El Hafsi K; Lysandropoulos AP
Clin Ther; 2016 Mar; 38(3):670-5. PubMed ID: 26856928
[TBL] [Abstract][Full Text] [Related]
11. JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.
Agnihotri SP; Dang X; Carter JL; Fife TD; Bord E; Batson S; Koralnik IJ
Neurology; 2014 Aug; 83(8):727-32. PubMed ID: 25037207
[TBL] [Abstract][Full Text] [Related]
12. Killing Two Birds With One Stone: Effective Control of Both Non-Small Cell Lung Cancer and Progressive Multifocal Leukoencephalopathy With Atezolizumab, A Case Report.
Lambert N; El Moussaoui M; Ritacco C; Moïse M; Paulus A; Delvenne P; Baron F; Sadzot B; Maquet P
Front Immunol; 2022; 13():889148. PubMed ID: 35592313
[TBL] [Abstract][Full Text] [Related]
13. Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.
Calvi A; De Riz M; Pietroboni AM; Ghezzi L; Maltese V; Arighi A; Fumagalli GG; Jacini F; Donelli C; Comi G; Galimberti D; Scarpini E
Immunotherapy; 2014; 6(1):23-8. PubMed ID: 24341880
[TBL] [Abstract][Full Text] [Related]
14. Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.
Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ
J Clin Neurosci; 2015 Mar; 22(3):598-600. PubMed ID: 25523125
[TBL] [Abstract][Full Text] [Related]
15. Progressive Multifocal Leukoencephalopathy with Immune Reconstitution Inflammatory Syndrome (PML-IRIS): two case reports of successful treatment with mefloquine and a review of the literature.
Young BE; Yeo TR; Lim HT; Vong KY; Tan K; Lye DC; Lee CC
Ann Acad Med Singap; 2012 Dec; 41(12):620-4. PubMed ID: 23303123
[No Abstract] [Full Text] [Related]
16. Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?
Wattjes MP; Verhoeff L; Zentjens W; Killestein J; van Munster ET; Barkhof F; van Eijk JJ
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1176-7. PubMed ID: 23695498
[No Abstract] [Full Text] [Related]
17. Minimal supportive treatment in natalizumab-related PML in a MS patient.
Lalive PH; Bridel C; Ferfoglia RI; Kaiser L; Du Pasquier R; Barkhof F; Haller S
J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):354-5. PubMed ID: 24957322
[No Abstract] [Full Text] [Related]
18. Novel treatments for progressive multifocal leukoencephalopathy.
Bennett KM; Fernandes PM
Br J Hosp Med (Lond); 2020 Jul; 81(7):1-9. PubMed ID: 32730143
[TBL] [Abstract][Full Text] [Related]
19. Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.
Krey L; Raab P; Sherzay R; Berding G; Stoll M; Stangel M; Wegner F
Front Immunol; 2019; 10():1188. PubMed ID: 31191548
[No Abstract] [Full Text] [Related]
20. Successful treatment of HIV-associated progressive multifocal leukoencephalopathy with pembrolizumab.
Sim BZ; Smith LK; Yarwood T; Smith S
AIDS; 2022 Mar; 36(3):483-485. PubMed ID: 35084387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
